Device
MR-linac
MR-linac is a medical device with 4 clinical trials. Currently 4 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
4(100%)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
4
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Recruiting4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
4
Success Rate
N/A
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
recruiting4100%
Recent Activity
4 active trials
Showing 4 of 4
recruitingphase_2
Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC
NCT05709782
recruitingnot_applicable
MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)
NCT05183074
recruitingnot_applicable
Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Cancer
NCT06244537
recruiting
Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)
NCT06531681
Clinical Trials (4)
Showing 4 of 4 trials
NCT05709782Phase 2
Phase II Cohort of Spinal Stereotactic Radiotherapy in Patients Using a MR LINAC
NCT05183074Not Applicable
MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)
NCT06244537Not Applicable
Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Cancer
NCT06531681
Precision Radiotherapy for Tumours Using Magnetic Resonance-guided Linear Accelerator (MR-Linac)
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4